Obstetrics/Gynecology · Syracuse, NY
NPI
1720153497
Since 2006
Specialty
Obstetrics/Gynecology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
475 Irving Ave, Suite 108
Syracuse, NY, 13210
Phone (315) 671-0070
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
846 services
Medicare patients, 2024
253
Average age 72
Drug cost, 2024
$166K
1,038 prescriptions
Company payments, 2025
$34.31
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Byuong C Ryu was code G0328 (colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous), 144 times for 144 patients. In total Byuong C Ryu billed 846 services in 24 codes, and Medicare paid $34K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-06.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 144 | 144 | $14.60 | $2,102 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 136 | 136 | $36.66 | $4,985 |
| 99213 Office E&M - Established | Office | 105 | 64 | $54.23 | $5,694 |
| 77063 Mammography | Office | 105 | 105 | $22.02 | $2,312 |
| 77067 Mammography | Office | 105 | 105 | $84.65 | $8,888 |
| 77080 Standard X-ray | Office | 62 | 62 | $36.26 | $2,248 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 31 | 31 | $41.54 | $1,288 |
| 76830 Ultrasound - Abdomen and Pelvis | Office | 25 | 23 | $71.15 | $1,779 |
| 87800 Infectious Agent Detection by DNA/RNA | Office | 21 | 19 | $42.80 | $899 |
By year: 2022 $36K for 1,242 services; 2023 $33K for 1,058 services; 2024 $34K for 846 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 144 | 144 | $14.60 | $2,102 |
| 87800 Infectious Agent Detection by DNA/RNA | 21 | 19 | $42.80 | $899 |
Medicare prescription drug claims, 2024
In 2024, the drug Byuong C Ryu prescribed most often to Medicare patients was Estradiol, with 265 prescriptions and refills. In total Byuong C Ryu wrote 1,038 Medicare prescriptions that cost $166K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 265 | 784 | 101 | $26K |
| Premarin Estrogens, Conjugated | 126 | 303 | 40 | $52K |
| Estradiol (Twice Weekly) Estradiol | 51 | 123 | 15 | $5,615 |
| Medroxyprogesterone Acetate Generic | 48 | 133 | 16 | $792 |
| Ibandronate Sodium Generic | 46 | 114 | 14 | $1,089 |
| Estradiol-Norethindrone Acetat Estradiol/Norethindrone Acet | 45 | 119 | 16 | $5,501 |
| Fluconazole Generic | 40 | 40 | 27 | $114 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 40 | 41 | 25 | $1,055 |
| Valacyclovir Valacyclovir Hcl | 33 | 67 | 11 | $390 |
| Estradiol (Once Weekly) Estradiol | 30 | 82 | Under 11 | $3,365 |
| Alendronate Sodium Generic | 26 | 73 | Under 11 | $190 |
| Progesterone Progesterone, Micronized | 22 | 56 | Under 11 | $666 |
| Raloxifene Hcl Generic | 22 | 66 | Under 11 | $745 |
| Dotti Estradiol | 19 | 46 | Under 11 | $2,651 |
| Myrbetriq Mirabegron | 18 | 52 | Under 11 | $23K |
Brand drugs: 256 claims; generic drugs: 782 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Byuong C Ryu $34.31 ($34.31 in general payments such as food, travel and fees) from 1 company. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $34.31.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $34.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.